Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

Crisis and a little bit of nerve

Friday, December 19, 2014

On the 4-5th of December the forum “Successful project management in pharmaceutical industry of Russia and CIS”, organized by TBM Evolution Group took place in Moscow. At the forum RNC Pharma presented current market situation overview, latest regulation initiatives and political factors evaluation, as well as its suggested consequences for the whole pharmaceutical branch.

Current 2014-th year, contrarily to all expectations had not been critical for the pharmaceutical market, at least, all the demand indicators stayed quite stable. At the same time, this year brought us many events, which will have the most serious consequences for the market. First of all, the consolidation processes were activated in the sphere of chain retail, as well as in the medical wholesale sphere. Natural way, the consolidation of the market participants will not just lead to market shares redistribution, but also will seriously change the whole communication process between pharmaceutical companies and distributors, landlords, etc.

However, the most serious future changes are linked to political and regulatory factors. Among regulatory factors, the long-awaited list of amendments to the state law “On the pharmaceutical products circulation” can be named. At the same time, Ministry of Healthcare introduced the updated VED list, some changes in the governmental drug procurement procedure entered into force. However, regulatory initiatives significantly less influenced the market during the previous year, than political events. Among them the Crimea market join should be named, which means the TTL market growth, and of course, the sanctions, which followed in this regard from the Western countries are also critically important. And perhaps, the main factor, which will affect the future of Russian pharmaceutical market became ruble rate fluctuations towards USD and EUR. By the end of the year we can see a significant exchange rate collapse, stimulated by massive speculations on the forex market. The consequences of such events development for highly import-dependent industry would be crucial. However, it would largely depend on the crisis’ duration on the foreign exchange market, and on the stabilization level of Russian currency.

You can download the complete presentation by the link

Share: